{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "494f32ce",
   "metadata": {},
   "source": [
    "# ðŸ§ª MongoDB Query Performance Evaluation (Baseline)\n",
    "This notebook runs a set of core queries against the `openfda.full_reports` collection in MongoDB.\n",
    "It measures execution time to establish a performance baseline **before indexing**.\n",
    "\n",
    "Later, these same queries will be used to compare against:\n",
    "- âœ… Indexed MongoDB collection (e.g., `indexed_reports`)\n",
    "- âœ… SQLite database (once finalized)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "6f48a462",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pymongo import MongoClient\n",
    "import time\n",
    "\n",
    "# MongoDB connection\n",
    "client = MongoClient('mongodb://localhost:27017')\n",
    "db = client['openfda']\n",
    "collection = db['full_reports']"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52f18625",
   "metadata": {},
   "source": [
    "## Q0 â€“ Count All Reports in Collection\n",
    "\n",
    "Before running specific queries, it's useful to perform a quick sanity check to confirm that the MongoDB collection is populated as expected.\n",
    "\n",
    "This query counts all documents in the `full_reports` collection."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "beb718ea",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total Reports: 35999, Elapsed: 0.068735 seconds\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "35999"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def count_all_reports():\n",
    "    start_time = time.time()\n",
    "    count = collection.count_documents({})\n",
    "    elapsed = time.time() - start_time\n",
    "    print(f'Total Reports: {count}, Elapsed: {elapsed:.6f} seconds')\n",
    "    return count\n",
    "\n",
    "# Example\n",
    "count_all_reports()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "13d21797",
   "metadata": {},
   "source": [
    "## Q1 â€“ Find Report by `safetyreportid`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "bd463789",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Elapsed: 0.023175 seconds\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'_id': ObjectId('6819f1af7894e637cc60dc80'),\n",
       " 'safetyreportversion': '15',\n",
       " 'safetyreportid': '19854733',\n",
       " 'primarysourcecountry': 'CA',\n",
       " 'occurcountry': 'CA',\n",
       " 'transmissiondateformat': '102',\n",
       " 'transmissiondate': '20240409',\n",
       " 'reporttype': '1',\n",
       " 'serious': '1',\n",
       " 'seriousnessdeath': '2',\n",
       " 'seriousnesslifethreatening': '2',\n",
       " 'seriousnesshospitalization': '1',\n",
       " 'seriousnessdisabling': '2',\n",
       " 'seriousnesscongenitalanomali': '2',\n",
       " 'seriousnessother': '1',\n",
       " 'receivedateformat': '102',\n",
       " 'receivedate': '20210920',\n",
       " 'receiptdateformat': '102',\n",
       " 'receiptdate': '20240112',\n",
       " 'fulfillexpeditecriteria': '1',\n",
       " 'companynumb': 'CA-CELLTRION INC.-2021CA001620',\n",
       " 'duplicate': '1',\n",
       " 'reportduplicate': [{'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'},\n",
       "  {'duplicatesource': 'PFIZER INC',\n",
       "   'duplicatenumb': 'CA-PFIZER INC-2021085662'}],\n",
       " 'primarysource': {'reportercountry': 'CA', 'qualification': '3'},\n",
       " 'sender': {'sendertype': '2', 'senderorganization': 'FDA-Public Use'},\n",
       " 'receiver': {'receivertype': '6', 'receiverorganization': 'FDA'},\n",
       " 'patient': {'reaction': [{'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Intestinal obstruction',\n",
       "    'reactionoutcome': '3'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Blood iron decreased',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Inguinal hernia',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Back pain',\n",
       "    'reactionoutcome': '2'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Condition aggravated',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Arthralgia',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Inflammation',\n",
       "    'reactionoutcome': '3'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Diverticulitis',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Abscess',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Abdominal pain',\n",
       "    'reactionoutcome': '3'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Therapeutic response shortened',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Mass',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Faecal calprotectin increased',\n",
       "    'reactionoutcome': '3'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'COVID-19',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Urinary tract infection',\n",
       "    'reactionoutcome': '1'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Off label use',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Off label use',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Intentional product use issue',\n",
       "    'reactionoutcome': '6'},\n",
       "   {'reactionmeddraversionpt': '26.1',\n",
       "    'reactionmeddrapt': 'Mucous stools',\n",
       "    'reactionoutcome': '3'}],\n",
       "  'drug': [{'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG, AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (WEEK 0 DOSE)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugindication': 'Crohn^s disease',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20201020',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20201020',\n",
       "    'drugtreatmentduration': '1',\n",
       "    'drugtreatmentdurationunit': '804',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG, AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (WEEK 2 DOSE)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20201104',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20201104',\n",
       "    'drugtreatmentduration': '1',\n",
       "    'drugtreatmentdurationunit': '804',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG, EVERY 4 WEEK (WEEK 2 DOSE)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20201104',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20201104',\n",
       "    'drugtreatmentduration': '1',\n",
       "    'drugtreatmentdurationunit': '804',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'DY0029',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG, AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (WEEK 6 DOSE)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20201203',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20201203',\n",
       "    'drugtreatmentduration': '1',\n",
       "    'drugtreatmentdurationunit': '804',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'EG4599',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210127',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20210127',\n",
       "    'drugtreatmentduration': '115',\n",
       "    'drugtreatmentdurationunit': '806',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'EG4601',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210326',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210520',\n",
       "    'drugenddateformat': '102',\n",
       "    'drugenddate': '20210520',\n",
       "    'drugtreatmentduration': '65',\n",
       "    'drugtreatmentdurationunit': '806',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'ER2661',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210715',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210909',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '300',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '300 MG EVERY 8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220106',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'FH4212',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK  ROUNDED UP TO UPPER VIAL',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220303',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'FF1286',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK ROUNDED UP TO UPPER VIAL',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220428',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'GF416324',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK ROUNDED UP TO UPPER VIAL',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220622',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK ROUNDED UP TO UPPER VIAL',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220818',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'GW3134',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '500',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '500 MG, Q8 WEEKS',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20230720',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'HC7043',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK ROUNDED UP TO UPPER VIAL',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20230914',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'HE7706',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '10',\n",
       "    'drugstructuredosageunit': '007',\n",
       "    'drugdosagetext': '10 MG/KG, EVERY 8 WEEK ROUNDED UP TO UPPER VIAL (500 MG)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugadministrationroute': '042',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20231109',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugbatchnumb': 'HG4838',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '500',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '500 MG, REINTRODUTION WEEK 0',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20231211',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '1',\n",
       "    'medicinalproduct': 'INFLECTRA',\n",
       "    'drugauthorizationnumb': '125544',\n",
       "    'drugstructuredosagenumb': '500',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '500 MG, REINTRODUTION (WEEK 2 INDUCTION DOSE)',\n",
       "    'drugdosageform': 'Powder for injection',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20231228',\n",
       "    'actiondrug': '4',\n",
       "    'activesubstance': {'activesubstancename': 'INFLIXIMAB-DYYB'},\n",
       "    'openfda': {'application_number': ['BLA125544'],\n",
       "     'brand_name': ['INFLECTRA'],\n",
       "     'generic_name': ['INFLIXIMAB-DYYB'],\n",
       "     'manufacturer_name': ['Pfizer Laboratories Div Pfizer Inc'],\n",
       "     'product_ndc': ['0069-0809'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['INFLIXIMAB'],\n",
       "     'rxcui': ['1790541', '1790546'],\n",
       "     'spl_id': ['a5dd5a76-f04d-4b09-9ece-ef410023ed2d'],\n",
       "     'spl_set_id': ['37eaca10-d812-48bc-8b8e-b836bfa9968f'],\n",
       "     'package_ndc': ['0069-0809-01'],\n",
       "     'nui': ['N0000175610', 'N0000175451'],\n",
       "     'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "     'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "     'unii': ['B72HH48FLU']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'CALCIUM',\n",
       "    'drugstructuredosagenumb': '500',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '500 MG, 1X/DAY',\n",
       "    'drugindication': 'Menopause',\n",
       "    'activesubstance': {'activesubstancename': 'CALCIUM'},\n",
       "    'openfda': {'brand_name': ['7030 CALCIUM PREMIUM',\n",
       "      'AG-X',\n",
       "      '7030 CALCIUM GOLD'],\n",
       "     'generic_name': ['CALCIUM'],\n",
       "     'manufacturer_name': ['Apexel Co., Ltd', 'APEXEL CO., LTD.'],\n",
       "     'product_ndc': ['55259-1112', '55259-0007', '55259-0001'],\n",
       "     'product_type': ['HUMAN OTC DRUG'],\n",
       "     'route': ['ORAL'],\n",
       "     'substance_name': ['CALCIUM'],\n",
       "     'spl_id': ['0fa8135f-89c9-41a2-e063-6294a90a403d',\n",
       "      '11cc283a-fe2c-f101-e063-6294a90ad2d4',\n",
       "      '11cc310a-d82e-be44-e063-6394a90a227c'],\n",
       "     'spl_set_id': ['bdc7c833-daf7-48f9-e053-2995a90ad88e',\n",
       "      'bdee5e24-645b-7fa0-e053-2995a90a7d25',\n",
       "      'bdc7c088-83e3-20ce-e053-2995a90abd2f'],\n",
       "     'package_ndc': ['55259-1112-1', '55259-0007-1', '55259-0001-1'],\n",
       "     'nui': ['M0003153', 'N0000175901'],\n",
       "     'pharm_class_cs': ['Calcium [CS]'],\n",
       "     'pharm_class_epc': ['Calcium [EPC]'],\n",
       "     'unii': ['SY7Q814VUP']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'FERROUS SULFATE',\n",
       "    'drugdosagetext': '3000 3X/WEEK',\n",
       "    'drugindication': 'Anaemia',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210519',\n",
       "    'activesubstance': {'activesubstancename': 'FERROUS SULFATE'},\n",
       "    'openfda': {'brand_name': ['FERROUS SULFATE', 'FERRUM SULPHURICUM'],\n",
       "     'generic_name': ['FERROUS SULFATE'],\n",
       "     'manufacturer_name': ['Richmond Pharmaceuticals, Inc.',\n",
       "      'Boiron',\n",
       "      'Richmond Pharmaceuticals Inc.'],\n",
       "     'product_ndc': ['54738-963', '0220-2111'],\n",
       "     'product_type': ['HUMAN OTC DRUG'],\n",
       "     'route': ['ORAL'],\n",
       "     'substance_name': ['FERROUS SULFATE'],\n",
       "     'rxcui': ['310325'],\n",
       "     'spl_id': ['2a327c66-d561-6a9b-e063-6294a90a5d0a',\n",
       "      '0a0cbae3-25d2-6d47-e063-6294a90a0431',\n",
       "      '2a327df7-e75d-8130-e063-6294a90a6e83'],\n",
       "     'spl_set_id': ['58dd4f30-980b-44bc-9f8e-8d4626854b91',\n",
       "      '7a4087d8-d054-bbdc-e053-2991aa0ae8cf',\n",
       "      '5514d582-19b5-4f1e-b794-f790afb8211c'],\n",
       "     'package_ndc': ['54738-963-01',\n",
       "      '54738-963-03',\n",
       "      '0220-2111-41',\n",
       "      '54738-963-13'],\n",
       "     'unii': ['39R4TAN1VT']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'PURINETHOL',\n",
       "    'drugstructuredosagenumb': '25',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '25 MG, 1X/DAY',\n",
       "    'drugindication': 'Crohn^s disease',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20190924',\n",
       "    'activesubstance': {'activesubstancename': 'MERCAPTOPURINE'}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'PURINETHOL',\n",
       "    'drugstructuredosagenumb': '75',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '75 MG',\n",
       "    'drugindication': 'Anaemia',\n",
       "    'activesubstance': {'activesubstancename': 'MERCAPTOPURINE'}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'PURINETHOL',\n",
       "    'drugstructuredosagenumb': '25',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '25 MG',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20210126',\n",
       "    'activesubstance': {'activesubstancename': 'MERCAPTOPURINE'}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'PURINETHOL',\n",
       "    'drugstructuredosagenumb': '25',\n",
       "    'drugstructuredosageunit': '003',\n",
       "    'drugdosagetext': '25 MG',\n",
       "    'drugadministrationroute': '065',\n",
       "    'activesubstance': {'activesubstancename': 'MERCAPTOPURINE'}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'CYANOCOBALAMIN',\n",
       "    'drugdosagetext': '1200, 1X/DAY',\n",
       "    'drugindication': 'Vitamin B12 deficiency',\n",
       "    'drugstartdateformat': '602',\n",
       "    'drugstartdate': '2019',\n",
       "    'activesubstance': {'activesubstancename': 'CYANOCOBALAMIN'},\n",
       "    'openfda': {'application_number': ['ANDA206503',\n",
       "      'ANDA214655',\n",
       "      'ANDA213874',\n",
       "      'ANDA080737',\n",
       "      'ANDA209255',\n",
       "      'ANDA217839',\n",
       "      'ANDA214390',\n",
       "      'ANDA212458',\n",
       "      'ANDA080515',\n",
       "      'ANDA214316',\n",
       "      'NDA021642',\n",
       "      '505G(a)(3)',\n",
       "      'ANDA209429',\n",
       "      'ANDA210629',\n",
       "      'ANDA215417',\n",
       "      'ANDA080557',\n",
       "      'ANDA215107'],\n",
       "     'brand_name': ['CYANOCOBALAMIN',\n",
       "      'NASCOBAL',\n",
       "      'YIFUJIA PLANT ANTIBACTERIAL GEL'],\n",
       "     'generic_name': ['CYANOCOBALAMIN'],\n",
       "     'manufacturer_name': ['Somerset Therapeutics, LLC',\n",
       "      'Zydus Pharmaceuticals USA Inc.',\n",
       "      'AuroMedics Pharma LLC',\n",
       "      'BluePoint Laboratories',\n",
       "      'Vitruvias Therapeutics',\n",
       "      'Meitheal Pharmaceuticals Inc.',\n",
       "      'Padagis Israel Pharmaceuticals Ltd',\n",
       "      'Hikma Pharmaceuticals USA Inc.',\n",
       "      'ENDO USA, Inc.',\n",
       "      'Mecaso Great Health Industry (Guangdong) Co.,Ltd.',\n",
       "      'American Regent, Inc.',\n",
       "      'NorthStar RxLLC',\n",
       "      'Lupin Pharmaceuticals,Inc.',\n",
       "      'Gland Pharma Limited',\n",
       "      'SOLA Pharmaceuticals',\n",
       "      'Lifestar Pharma LLC',\n",
       "      'Fresenius Kabi USA, LLC',\n",
       "      'Zydus Lifesciences Limited',\n",
       "      'Sagent Pharmaceuticals'],\n",
       "     'product_ndc': ['70069-005',\n",
       "      '70069-172',\n",
       "      '70710-1663',\n",
       "      '70710-1664',\n",
       "      '70710-1665',\n",
       "      '55150-364',\n",
       "      '68001-542',\n",
       "      '69680-112',\n",
       "      '69680-113',\n",
       "      '69680-121',\n",
       "      '68001-640',\n",
       "      '71288-303',\n",
       "      '45802-491',\n",
       "      '0143-9619',\n",
       "      '0143-9621',\n",
       "      '0143-9620',\n",
       "      '71288-300',\n",
       "      '71288-301',\n",
       "      '71288-302',\n",
       "      '49884-270',\n",
       "      '84341-002',\n",
       "      '0517-0031',\n",
       "      '0517-0032',\n",
       "      '0517-0130',\n",
       "      '70069-171',\n",
       "      '72603-650',\n",
       "      '43386-237',\n",
       "      '68083-449',\n",
       "      '68083-561',\n",
       "      '68083-562',\n",
       "      '70512-840',\n",
       "      '70756-635',\n",
       "      '70756-636',\n",
       "      '63323-044',\n",
       "      '70771-1688',\n",
       "      '70771-1689',\n",
       "      '70771-1690',\n",
       "      '25021-502'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG', 'HUMAN OTC DRUG'],\n",
       "     'route': ['INTRAMUSCULAR', 'SUBCUTANEOUS', 'NASAL', 'TOPICAL'],\n",
       "     'substance_name': ['CYANOCOBALAMIN'],\n",
       "     'rxcui': ['309594', '861113', '861115'],\n",
       "     'spl_id': ['0e24643e-b0c4-42ab-a1c9-f7a170ee8d76',\n",
       "      '6ac6e28b-b969-4b66-bc1e-cca8a2cb66f3',\n",
       "      'a0566c8d-7cb0-4ee7-8599-f2e8dc8992c7',\n",
       "      'fab6a2d8-d9a0-2f8f-e053-6394a90a22bc',\n",
       "      '7c3b0e85-bd17-4998-aaf4-1a873a357ab4',\n",
       "      '2b45cb57-1459-d2e8-e063-6394a90a2475',\n",
       "      '8a611106-589f-4896-baa7-653137dc27ab',\n",
       "      '4cf650d9-6d6c-4112-88f2-cd2e94f1f416',\n",
       "      '18a5677c-6c35-4613-9064-21bf488cf57b',\n",
       "      'b2ee60e7-c10a-45e1-81e8-28d6838161eb',\n",
       "      'bd8722ab-7ac0-4e01-8244-36e8d83eca8d',\n",
       "      '18f444e6-65f5-5604-e063-6294a90ab5d8',\n",
       "      '28421ba1-7e37-429c-9c66-62cc36f5847c',\n",
       "      '9f0dee6d-ee88-43df-9e7b-a3f345734210',\n",
       "      'bdfaf6c3-67ca-4323-a93e-72eba47805d9',\n",
       "      'bb7b94e1-b5cd-486f-9e34-38fc9595547a',\n",
       "      '771cf601-8f92-4e4f-a29f-b18e71b1ba96',\n",
       "      '18e5b395-ba7a-d30f-e063-6394a90a5832',\n",
       "      '3042bb7f-f286-4fc4-8755-67adce1c71c0',\n",
       "      '65f0f72b-691f-4cbb-a5d7-7579a133f457',\n",
       "      '0a2dc386-15b3-45a3-91d7-80b9cf202c03',\n",
       "      '8940ec64-b0cd-4f10-bc19-251146c9e552',\n",
       "      '634b55ef-9667-46f7-9b3e-d41f4b7b819b',\n",
       "      'b1dd7657-05bd-4062-89f1-9e11f0042f3e'],\n",
       "     'spl_set_id': ['41ac0dc1-0a71-4c69-8e25-ba838f5f16a3',\n",
       "      'e6712877-ace0-441c-99a9-adf567c0b9a2',\n",
       "      'db84d0ea-5c15-47f5-bbe2-8d455e75695e',\n",
       "      'cdd4fd12-e214-43a6-b560-d56fc0d87190',\n",
       "      '2117af8a-723f-4e2f-98a6-83ad2c423751',\n",
       "      '5c603ad0-9023-44cc-955c-3988d5dcf0d3',\n",
       "      'c6436212-9246-4e29-8540-9af992b667eb',\n",
       "      '971e5f30-55c2-4193-9dd8-b43a1862b92a',\n",
       "      'a66eb3c4-3e1d-4d49-b963-4fa2334cc9b6',\n",
       "      '9c37fd25-2143-410c-8d89-d39aa5c7b453',\n",
       "      '697e0e52-c01b-4b53-9994-f79c46eb6b4f',\n",
       "      '18f444e6-65f4-5604-e063-6294a90ab5d8',\n",
       "      '2fb653d6-e2b2-4969-831b-c0dc37b9c0cc',\n",
       "      '617e44f8-df80-4764-85b9-be0fb6da8db3',\n",
       "      'ce0183b3-4410-466a-b57d-cd360d461b7c',\n",
       "      'efb7dc02-f0c9-4537-9e23-b641c428068c',\n",
       "      'cd8d188a-fa5d-4580-bcb1-ac8617118cbb',\n",
       "      'e559c6c8-2973-77fb-e053-2995a90af43d',\n",
       "      'b1e35c97-2157-454e-967f-53a4300827de',\n",
       "      'ccf5b124-083d-4465-a666-c1bc6e84d630',\n",
       "      '8b1cdee5-3368-40e4-90bf-31a64df1f38a',\n",
       "      'ef300a08-8212-40a9-847a-1b62348896dd',\n",
       "      'acff4ff3-4435-4995-a117-dbfcdf72334a',\n",
       "      '7e10c47d-1036-47c1-a0ed-6929636366c2'],\n",
       "     'package_ndc': ['70069-005-01',\n",
       "      '70069-005-10',\n",
       "      '70069-172-01',\n",
       "      '70069-172-10',\n",
       "      '70069-172-25',\n",
       "      '70710-1663-1',\n",
       "      '70710-1663-7',\n",
       "      '70710-1664-1',\n",
       "      '70710-1664-6',\n",
       "      '70710-1664-7',\n",
       "      '70710-1665-1',\n",
       "      '70710-1665-5',\n",
       "      '55150-364-01',\n",
       "      '55150-364-10',\n",
       "      '55150-364-25',\n",
       "      '68001-542-59',\n",
       "      '68001-542-60',\n",
       "      '69680-112-01',\n",
       "      '69680-112-25',\n",
       "      '69680-112-10',\n",
       "      '69680-113-10',\n",
       "      '69680-113-99',\n",
       "      '69680-121-05',\n",
       "      '69680-121-30',\n",
       "      '69680-121-10',\n",
       "      '68001-640-59',\n",
       "      '68001-640-60',\n",
       "      '71288-303-91',\n",
       "      '71288-303-92',\n",
       "      '45802-491-84',\n",
       "      '0143-9621-01',\n",
       "      '0143-9621-25',\n",
       "      '0143-9620-01',\n",
       "      '0143-9620-10',\n",
       "      '0143-9619-01',\n",
       "      '0143-9619-10',\n",
       "      '71288-300-01',\n",
       "      '71288-300-02',\n",
       "      '71288-301-10',\n",
       "      '71288-301-11',\n",
       "      '71288-302-30',\n",
       "      '49884-270-82',\n",
       "      '49884-270-52',\n",
       "      '84341-002-01',\n",
       "      '0517-0031-01',\n",
       "      '0517-0031-25',\n",
       "      '0517-0032-01',\n",
       "      '0517-0032-25',\n",
       "      '0517-0130-01',\n",
       "      '70069-171-05',\n",
       "      '70069-171-10',\n",
       "      '72603-650-01',\n",
       "      '72603-650-25',\n",
       "      '43386-237-70',\n",
       "      '43386-237-60',\n",
       "      '68083-449-25',\n",
       "      '68083-561-25',\n",
       "      '68083-562-01',\n",
       "      '70512-840-01',\n",
       "      '70512-840-25',\n",
       "      '70756-635-10',\n",
       "      '70756-635-25',\n",
       "      '70756-636-25',\n",
       "      '70756-636-10',\n",
       "      '71288-303-01',\n",
       "      '71288-303-02',\n",
       "      '63323-044-41',\n",
       "      '63323-044-44',\n",
       "      '70771-1688-1',\n",
       "      '70771-1688-7',\n",
       "      '70771-1689-1',\n",
       "      '70771-1689-6',\n",
       "      '70771-1689-7',\n",
       "      '70771-1690-1',\n",
       "      '70771-1690-5',\n",
       "      '63323-044-00',\n",
       "      '63323-044-01',\n",
       "      '25021-502-01'],\n",
       "     'nui': ['M0022794', 'N0000175951'],\n",
       "     'pharm_class_cs': ['Vitamin B 12 [CS]'],\n",
       "     'pharm_class_epc': ['Vitamin B12 [EPC]'],\n",
       "     'unii': ['P6YC3EG204']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'VENOFER',\n",
       "    'drugdosagetext': 'UNK',\n",
       "    'drugindication': 'Anaemia',\n",
       "    'activesubstance': {'activesubstancename': 'IRON SUCROSE'},\n",
       "    'openfda': {'application_number': ['NDA021135'],\n",
       "     'brand_name': ['VENOFER'],\n",
       "     'generic_name': ['IRON SUCROSE'],\n",
       "     'manufacturer_name': ['Fresenius Medical Care Holdings, Inc.',\n",
       "      'American Regent, Inc.'],\n",
       "     'product_ndc': ['49230-530',\n",
       "      '49230-534',\n",
       "      '0517-2310',\n",
       "      '0517-2325',\n",
       "      '0517-2340'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['IRON SUCROSE'],\n",
       "     'rxcui': ['1741267',\n",
       "      '1741268',\n",
       "      '1741270',\n",
       "      '1741271',\n",
       "      '1741261',\n",
       "      '1741263'],\n",
       "     'spl_id': ['d169adb0-d1dc-4c19-99b4-f1dce90db380',\n",
       "      '1cb19ad9-7a23-43bd-ab28-955cd2fa3750',\n",
       "      '91f50fe2-b85d-460d-86a8-469cc16f6a99'],\n",
       "     'spl_set_id': ['f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040',\n",
       "      '626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a',\n",
       "      'b998ef36-81fa-40a1-9cd1-6d6156f91564'],\n",
       "     'package_ndc': ['49230-530-01',\n",
       "      '49230-530-10',\n",
       "      '49230-530-25',\n",
       "      '49230-534-01',\n",
       "      '49230-534-10',\n",
       "      '49230-534-25',\n",
       "      '0517-2325-01',\n",
       "      '0517-2325-10',\n",
       "      '0517-2340-01',\n",
       "      '0517-2340-10',\n",
       "      '0517-2340-25',\n",
       "      '0517-2310-01',\n",
       "      '0517-2310-05',\n",
       "      '0517-2340-99'],\n",
       "     'nui': ['M0011718', 'N0000177913'],\n",
       "     'pharm_class_cs': ['Iron [CS]'],\n",
       "     'pharm_class_epc': ['Parenteral Iron Replacement [EPC]'],\n",
       "     'unii': ['FZ7NYF5N8L']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'VENOFER',\n",
       "    'drugdosagetext': 'UNK',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220729',\n",
       "    'activesubstance': {'activesubstancename': 'IRON SUCROSE'},\n",
       "    'openfda': {'application_number': ['NDA021135'],\n",
       "     'brand_name': ['VENOFER'],\n",
       "     'generic_name': ['IRON SUCROSE'],\n",
       "     'manufacturer_name': ['Fresenius Medical Care Holdings, Inc.',\n",
       "      'American Regent, Inc.'],\n",
       "     'product_ndc': ['49230-530',\n",
       "      '49230-534',\n",
       "      '0517-2310',\n",
       "      '0517-2325',\n",
       "      '0517-2340'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['IRON SUCROSE'],\n",
       "     'rxcui': ['1741267',\n",
       "      '1741268',\n",
       "      '1741270',\n",
       "      '1741271',\n",
       "      '1741261',\n",
       "      '1741263'],\n",
       "     'spl_id': ['d169adb0-d1dc-4c19-99b4-f1dce90db380',\n",
       "      '1cb19ad9-7a23-43bd-ab28-955cd2fa3750',\n",
       "      '91f50fe2-b85d-460d-86a8-469cc16f6a99'],\n",
       "     'spl_set_id': ['f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040',\n",
       "      '626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a',\n",
       "      'b998ef36-81fa-40a1-9cd1-6d6156f91564'],\n",
       "     'package_ndc': ['49230-530-01',\n",
       "      '49230-530-10',\n",
       "      '49230-530-25',\n",
       "      '49230-534-01',\n",
       "      '49230-534-10',\n",
       "      '49230-534-25',\n",
       "      '0517-2325-01',\n",
       "      '0517-2325-10',\n",
       "      '0517-2340-01',\n",
       "      '0517-2340-10',\n",
       "      '0517-2340-25',\n",
       "      '0517-2310-01',\n",
       "      '0517-2310-05',\n",
       "      '0517-2340-99'],\n",
       "     'nui': ['M0011718', 'N0000177913'],\n",
       "     'pharm_class_cs': ['Iron [CS]'],\n",
       "     'pharm_class_epc': ['Parenteral Iron Replacement [EPC]'],\n",
       "     'unii': ['FZ7NYF5N8L']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'VENOFER',\n",
       "    'drugdosagetext': 'UNK',\n",
       "    'drugstartdateformat': '102',\n",
       "    'drugstartdate': '20220805',\n",
       "    'activesubstance': {'activesubstancename': 'IRON SUCROSE'},\n",
       "    'openfda': {'application_number': ['NDA021135'],\n",
       "     'brand_name': ['VENOFER'],\n",
       "     'generic_name': ['IRON SUCROSE'],\n",
       "     'manufacturer_name': ['Fresenius Medical Care Holdings, Inc.',\n",
       "      'American Regent, Inc.'],\n",
       "     'product_ndc': ['49230-530',\n",
       "      '49230-534',\n",
       "      '0517-2310',\n",
       "      '0517-2325',\n",
       "      '0517-2340'],\n",
       "     'product_type': ['HUMAN PRESCRIPTION DRUG'],\n",
       "     'route': ['INTRAVENOUS'],\n",
       "     'substance_name': ['IRON SUCROSE'],\n",
       "     'rxcui': ['1741267',\n",
       "      '1741268',\n",
       "      '1741270',\n",
       "      '1741271',\n",
       "      '1741261',\n",
       "      '1741263'],\n",
       "     'spl_id': ['d169adb0-d1dc-4c19-99b4-f1dce90db380',\n",
       "      '1cb19ad9-7a23-43bd-ab28-955cd2fa3750',\n",
       "      '91f50fe2-b85d-460d-86a8-469cc16f6a99'],\n",
       "     'spl_set_id': ['f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040',\n",
       "      '626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a',\n",
       "      'b998ef36-81fa-40a1-9cd1-6d6156f91564'],\n",
       "     'package_ndc': ['49230-530-01',\n",
       "      '49230-530-10',\n",
       "      '49230-530-25',\n",
       "      '49230-534-01',\n",
       "      '49230-534-10',\n",
       "      '49230-534-25',\n",
       "      '0517-2325-01',\n",
       "      '0517-2325-10',\n",
       "      '0517-2340-01',\n",
       "      '0517-2340-10',\n",
       "      '0517-2340-25',\n",
       "      '0517-2310-01',\n",
       "      '0517-2310-05',\n",
       "      '0517-2340-99'],\n",
       "     'nui': ['M0011718', 'N0000177913'],\n",
       "     'pharm_class_cs': ['Iron [CS]'],\n",
       "     'pharm_class_epc': ['Parenteral Iron Replacement [EPC]'],\n",
       "     'unii': ['FZ7NYF5N8L']}},\n",
       "   {'drugcharacterization': '2',\n",
       "    'medicinalproduct': 'VIT D [VITAMIN D NOS]',\n",
       "    'drugseparatedosagenumb': '1',\n",
       "    'drugintervaldosageunitnumb': '1',\n",
       "    'drugintervaldosagedefinition': '803',\n",
       "    'drugdosagetext': '10000, WEEKLY',\n",
       "    'drugindication': 'Vitamin D deficiency',\n",
       "    'drugstartdateformat': '602',\n",
       "    'drugstartdate': '2019'}],\n",
       "  'summary': {'narrativeincludeclinical': 'CASE EVENT DATE: 20201104'}}}"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def query_by_safetyreportid(report_id):\n",
    "    start_time = time.time()\n",
    "    result = collection.find_one({'safetyreportid': str(report_id)})\n",
    "    elapsed = time.time() - start_time\n",
    "    print(f'Elapsed: {elapsed:.6f} seconds')\n",
    "    return result\n",
    "\n",
    "# Example\n",
    "query_by_safetyreportid('19854733')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f03e54c",
   "metadata": {},
   "source": [
    "## Q2 â€“ Count Reports Where `serious == 1`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "fcff4699",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Count: 20375, Elapsed: 0.050486 seconds\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "20375"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def count_serious_reports():\n",
    "    start_time = time.time()\n",
    "    count = collection.count_documents({'serious': \"1\"})\n",
    "    elapsed = time.time() - start_time\n",
    "    print(f'Count: {count}, Elapsed: {elapsed:.6f} seconds')\n",
    "    return count\n",
    "\n",
    "# Example\n",
    "count_serious_reports()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "500f0f61",
   "metadata": {},
   "source": [
    "## Q3 â€“ Count Reports by `receivedate` Year"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ec7ab834",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Elapsed: 0.193533 seconds\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[{'_id': '2007', 'count': 2},\n",
       " {'_id': '2008', 'count': 2},\n",
       " {'_id': '2010', 'count': 3},\n",
       " {'_id': '2012', 'count': 2},\n",
       " {'_id': '2013', 'count': 1},\n",
       " {'_id': '2014', 'count': 10},\n",
       " {'_id': '2015', 'count': 23},\n",
       " {'_id': '2016', 'count': 55},\n",
       " {'_id': '2017', 'count': 91},\n",
       " {'_id': '2018', 'count': 110},\n",
       " {'_id': '2019', 'count': 186},\n",
       " {'_id': '2020', 'count': 298},\n",
       " {'_id': '2021', 'count': 580},\n",
       " {'_id': '2022', 'count': 1521},\n",
       " {'_id': '2023', 'count': 7257},\n",
       " {'_id': '2024', 'count': 25858}]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def count_by_year():\n",
    "    pipeline = [\n",
    "        {'$project': {'year': {'$substr': ['$receivedate', 0, 4]}}},\n",
    "        {'$group': {'_id': '$year', 'count': {'$sum': 1}}},\n",
    "        {'$sort': {'_id': 1}}\n",
    "    ]\n",
    "    start_time = time.time()\n",
    "    results = list(collection.aggregate(pipeline))\n",
    "    elapsed = time.time() - start_time\n",
    "    print(f'Elapsed: {elapsed:.6f} seconds')\n",
    "    return results\n",
    "\n",
    "# Example\n",
    "count_by_year()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2b9feef7",
   "metadata": {},
   "source": [
    "## Q4 â€“ Find Reports for a Specific `drugname`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "e945f88b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 1188 reports for 'aspirin' (showing up to 5) in 3.574678 seconds\n",
      "17998181\n",
      "23656546\n",
      "18981049\n",
      "22802248\n",
      "23382421\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "1188"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def find_reports_by_drugname(drug_name, preview_limit=5):\n",
    "    query = {\n",
    "        'patient.drug.medicinalproduct': {\n",
    "            '$regex': f'^{drug_name}$',\n",
    "            '$options': 'i'  # Case-insensitive\n",
    "        }\n",
    "    }\n",
    "\n",
    "    start_time = time.time()\n",
    "    count = collection.count_documents(query)\n",
    "    results = list(collection.find(query).limit(preview_limit))\n",
    "    elapsed = time.time() - start_time\n",
    "\n",
    "    print(f\"Found {count} reports for '{drug_name}' (showing up to {preview_limit}) in {elapsed:.6f} seconds\")\n",
    "    for r in results:\n",
    "        print(r.get('safetyreportid'))\n",
    "\n",
    "    return count\n",
    "\n",
    "find_reports_by_drugname('aspirin', preview_limit=5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "641c8a29",
   "metadata": {},
   "source": [
    "## Q5 â€“ Fatal Reports with `drugindication == 'headache'`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "64b816dd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 3 fatal headache reports (showing up to 5) in 0.216393 seconds\n",
      "23458086\n",
      "23604512\n",
      "23427798\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "3"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def find_fatal_headache_reports(preview_limit=5):\n",
    "    query = {\n",
    "        'seriousnessdeath': \"1\",  # stored as string in OpenFDA\n",
    "        'patient.drug.drugindication': {\n",
    "            '$regex': '^headache$',\n",
    "            '$options': 'i'\n",
    "        }\n",
    "    }\n",
    "\n",
    "    start_time = time.time()\n",
    "    count = collection.count_documents(query)\n",
    "    results = list(collection.find(query).limit(preview_limit))\n",
    "    elapsed = time.time() - start_time\n",
    "\n",
    "    print(f\"Found {count} fatal headache reports (showing up to {preview_limit}) in {elapsed:.6f} seconds\")\n",
    "    for r in results:\n",
    "        print(r.get('safetyreportid'))\n",
    "\n",
    "    return count\n",
    "\n",
    "# Find fatal reports with drug indication 'headache', preview up to 5\n",
    "find_fatal_headache_reports(preview_limit=5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bed8782b",
   "metadata": {},
   "source": [
    "# Debugging - To delete later"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "34dbf697",
   "metadata": {},
   "outputs": [],
   "source": [
    "sample = collection.find_one(\n",
    "    {\"drug.medicinalproduct\": {\"$exists\": True}},\n",
    "    {\"safetyreportid\": 1, \"drug.medicinalproduct\": 1}\n",
    ")\n",
    "sample\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "88d1cd23",
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "'NoneType' object is not subscriptable",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[17], line 2\u001b[0m\n\u001b[0;32m      1\u001b[0m doc \u001b[38;5;241m=\u001b[39m collection\u001b[38;5;241m.\u001b[39mfind_one({\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdrug\u001b[39m\u001b[38;5;124m\"\u001b[39m: {\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m$exists\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;28;01mTrue\u001b[39;00m}}, {\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdrug\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;241m1\u001b[39m})\n\u001b[1;32m----> 2\u001b[0m \u001b[43mdoc\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mdrug\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\n",
      "\u001b[1;31mTypeError\u001b[0m: 'NoneType' object is not subscriptable"
     ]
    }
   ],
   "source": [
    "doc = collection.find_one({\"drug\": {\"$exists\": True}}, {\"drug\": 1})\n",
    "doc[\"drug\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "68b6a466",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "gen_ML",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
